VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Klodronate and Kliogest
Preclinical
Small molecule
K
Kuopio University Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hormone Replacement Therapy
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hormone Replacement Therapy
Preclinical
Completed
Clinical
Trials by Indication
[1]
Hormone Replacement Therapy
1 trial
Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
Completed
·
K
Kuopio University Hospital
·
N/A
·
NCT00877097
·
167 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Klodronate and Kliogest. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Klodronate and Kliogest compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Klodronate and Kliogest. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Kuopio University Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
K
Kuopio University Hospital
Related News